Implantable cardioverter defibrillator endocarditis caused by Klebsiella pneumoniae complicated by liver abscess and septic pulmonary embolism

Implantable cardioverter defibrillator endocarditis caused by Klebsiella pneumoniae complicated by liver abscess and septic pulmonary embolism

A 63-year old diabetic male patient carrying an implantable cardioverter defibrillator (ICD) was hospitalized with a 7- day history of fever, notwithstanding an antibiotic therapy. The white-blood cell count was 11,000/mm<sup>3</sup>, the platelet count was 135,000/mm<sup>3</sup...

Full description

Bibliographic Details
Main Authors:	Ilaria Izzo, Stefano Ettori, Paolo Colombini, Marco Cannata, Adriano Pagani, Daniele Bella
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-11-01
Series:	Italian Journal of Medicine
Subjects:	implatable cardioverter defibrillator, endocarditis, Klebsiella pneumoniae, liver abscess.
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/407

Similar Items

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

Implantable cardioverter-defibrillators step by step : an illustrated guide /
by: 439461 Stroobandt, Roland X., et al.
Published: (2009)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Combination of a leadless pacemaker and subcutaneous implantable cardioverter defibrillator therapy for a Japanese patient with prosthetic valve endocarditis
by: Ryo Ito, et al.
Published: (2019-04-01)

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
by: Johanna Mueller‐Leisse, et al.
Published: (2021-12-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Implantable Cardioverter Defibrillator Stored ECGs [electronic resource]: Clinical Management and Case Reports/
by: 410467 Jordaens, Luc J., et al.
Published: (2007)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
by: Ataallah Bagherzadeh, et al.
Published: (2006-04-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Favorable Trend of Implantable Cardioverter‐Defibrillator Service Life in a Large Single‐Nation Population: Insights From 10‐Year Analysis of the Italian Implantable Cardioverter‐Defibrillator Registry
by: Stefano Poli, et al.
Published: (2019-08-01)

Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014-11-01)

Living With Implantable Cardioverter Defibrillator: A phenomenological Study
by: Mohammad Abbasi, et al.
Published: (2014-11-01)

Implantable cardioverter-defibrillator oversensing due to electric shock
by: Jurčević Ružica, et al.
Published: (2010-01-01)

Implantable cardioverter defibrillators: Uses, abuses, gains and complications
by: Weiwei Li, et al.
Published: (2017-04-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Pregnancy and delivery in woman with implantable cardioverter-defibrillator: what we should know
by: Mohamed Amine Bouslama, et al.
Published: (2018-07-01)

The first cardioverter defibrillator implanted in Central Africa
by: Tantchou Tchoumi Jacques Cabral, et al.
Published: (2016-03-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
by: Marit van Barreveld, et al.
Published: (2021-04-01)

Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
by: Noriko Kikuchi, et al.
Published: (2024-12-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
by: Daniel B. Kramer, et al.
Published: (2015-05-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
by: Florian Blaschke, et al.
Published: (2021-08-01)

Adaptation status and related factors in patients living with implantable cardioverter defibrillators
by: Mohammadreza Razavi, et al.
Published: (2022-01-01)

An unusual cause of recurrent syncope in a patient with implantable cardioverter defibrillator
by: Armando Gardini, et al.
Published: (2015-07-01)